Clinical Trials List
2022-06-01 - 2023-09-06
Phase II
Terminated7
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- JOWY TANI 無
- 李靜娥 無
- Hung-Ju Chen 無
- Hsing-Yu Weng 無
- 謝瑞瑜 無
- 黃怡臻 無
- Chih-Shan Huang 無
- Chin-I Chen 無
- Yi-Chen Lin 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 吳孟儒 無
- Chou-Ching Lin 無
- 林典佑 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張君瑋 無
- 張宏旭 無
- 呂榮國 無
- 朱俊哲 無
- Hong-Chou Kuo 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Ching-Hua Lu Lu 未分科
- Fu-Yu Lin 未分科
- Kang-Hsu Lin 未分科
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- HSUEH-WEN HSUEH 無
- SUNG-TSANG HSIEH 無
- 鄭章佑 無
- 江樸田 無
- Ming-Jen Lee 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14-21 participants
-
Global
360 participants
